Resveratrol attenuates azidothymidine-induced cardiotoxicity by decreasing mitochondrial reactive oxygen species generation in human cardiomyocytes

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 151-155

  Gao, Rachel Yue ^a   Mukhopadhyay, Partha ^a   Mohanraj, Rajesh ^a   Wang, Hua ^b   Horváth, Béla ^a,c   Yin, Shi ^b   Pacher, Pál ^a  

^a Section on Oxidative Stress Tissue Injury   (Hungary)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Azidothymidine; Cardiomyocytes; Cell death; Reactive oxygen species; Resveratrol

Indexed keywords

CASPASE 3; CASPASE 7; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ZIDOVUDINE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BERRY; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVATION; GRAPE; HUMAN; HUMAN CELL; MITOCHONDRION; PEANUT; RED WINE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CASPASE 7; CELLS, CULTURED; HUMANS; MITOCHONDRIA; MYOCYTES, CARDIAC; REACTIVE OXYGEN SPECIES; STILBENES; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; VITACEAE;

EID: 78651403899     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.390     Document Type: Article

References (40)

1. Currie PF and Boon NA: Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS 17 (Suppl 1): 21-28, 2003.
2. De la Asuncion JG, Del Olmo ML, Gomez-Cambronero LG, Sastre J, Pallardo FV and Vina J: AZT induces oxidative damage to cardiac mitochondria: protective effect of vitamins C and E. Life Sci 76: 47-56, 2004.
3. Lewis W, Papoian T, Gonzalez B, et al: Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest 65: 228-236, 1991.
4. Lewis W, Simpson JF and Meyer RR: Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ Res 74: 344-348, 1994.
5. Mak IT, Goldfarb MG, Weglicki WB and Haudenschild CC: Cardiac pathologic effects of azidothymidine (AZT) in Mg-deficient mice. Cardiovasc Toxicol 4: 169-177, 2004.
6. Mak IT, Nedelec LF and Weglicki WB: Pro-oxidant properties and cytotoxicity of AZT-monophosphate and AZT. Cardiovasc Toxicol 4: 109-115, 2004.
7. Morris GW, Iams TA, Slepchenko KG and McKee EE: Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3′-azido-3′-deoxythymidine-dependent cardiotoxicity Biochem J 422: 513-520, 2009.
8. Sutliff RL, Dikalov S, Weiss D, et al: Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide. Am J Physiol Heart Circ Physiol 283: H2363-H2370, 2002.
9. Szabados E, Fischer GM, Toth K, et al: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 26: 309-317, 1999.
10. Freyssenet D, DiCarlo M, Escobar P, Grey J, Schneider J and Hood DA: Zidovudine (AZT) induced alterations in mitochondrial biogenesis in rat striated muscles. Can J Physiol Pharmacol 77: 29-35, 1999.
11. Kline ER, Bassit L, Hernandez-Santiago BI, et al: Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc Toxicol 9: 1-12, 2009.
12. Kohler JJ, Cucoranu I, Fields E, et al: Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy Lab Invest 89: 782-790, 2009.
13. Das DK and Maulik N: Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 6: 36-47, 2006.
14. Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews 5: 493-506, 2006.
15. Sharma S, Anjaneyulu M, Kulkarni SK and Chopra K: Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76: 69-75, 2006.
16. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al: Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43: 720-729, 2007.
17. Zang M, Xu S, Maitland-Toolan KA, et al: Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55: 2180-2191, 2006. (Pubitemid 44743614)
18. Barger JL, Kayo T, Vann JM, et al: A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3: e2264, 2008.
19. Baur JA, Pearson KJ, Price NL, et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006.
20. Csiszar A, Labinskyy N, Jimenez R, et al: Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev 130: 518-527, 2009.
21. Pearson KJ, Baur JA, Lewis KN, et al: Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8: 157-168, 2008.
22. Mukhopadhyay P, Rajesh M, Batkai S, et al: CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res 85: 773-784, 2010.
23. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M and Pacher P: Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2: 2295-2301, 2007. (Pubitemid 351565867)
24. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G and Pacher P: Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun 358: 203-208, 2007. (Pubitemid 46719103)
25. Mukhopadhyay P, Rajesh M, Batkai S, et al: Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 296: H1466-H1483, 2009.
26. Weglicki WB, Chmielinska JJ, Tejero-Taldo I, et al: Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 22: S167-S173, 2009.
27. Papparella I, Ceolotto G, Berto L, et al: Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 73: 432-438, 2007. (Pubitemid 44937699)
28. Pacher P and Szabo C: Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25: 235-260, 2007. (Pubitemid 47547464)
29. Pacher P, Beckman JS and Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007. (Pubitemid 46217686)
30. Levrand S, Vannay-Bouchiche C, Pesse B, et al: Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 41: 886-895, 2006. (Pubitemid 44262482)
31. Pacher P, Schulz R, Liaudet L and Szabo C: Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 26: 302-310, 2005. (Pubitemid 40733523)
32. Zhang H, Zhang J, Ungvari Z and Zhang C: Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29: 1164-1171, 2009.
33. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al: Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297: H1876-H1881, 2009.
34. Ungvari Z, Orosz Z, Rivera A, et al: Resveratrol increases vascular oxidative stress resistance. Am J Physiol 292: H2417-H2424, 2007. (Pubitemid 47084624)
35. Bradamante S, Barenghi L, Piccinini F, et al: Resveratrol provides late-phase cardioprotection by means of a nitric oxide-and adenosine-mediated mechanism. Eur J Pharmacol 465: 115-123, 2003. (Pubitemid 36332283)
36. Taubert D and Berkels R: Upregulation and activation of eNOS by resveratrol. Circulation 107: e78-79, 2003.
37. Csiszar A, Labinskyy N, Pinto JT, et al: Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297: H13-H20, 2009.
38. Yeung F, Hoberg JE, Ramsey CS, et al: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 23: 2369-2380, 2004. (Pubitemid 38954844)
39. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A and Ungvari Z: Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition. Am J Physiol 291: H1694-H1699, 2006. (Pubitemid 44497674)
40. Csiszar A, Labinskyy N, Podlutsky A, et al: Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 294: H2721-H2735, 2008.